• Post author:
  • Post category:Chemicals
  • Reading time:5 mins read
You are currently viewing Ortho Phthalaldehyde  Market Size Projected To Increase From $4.42 Billion To $5.6 Billion During The Forecast Period
Global Ortho Phthalaldehyde Market Trends

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Ortho Phthalaldehyde Market Growth Potential: How Will Market Size Change Through 2030?

The market size for ortho phthalaldehyde has demonstrated strong growth in recent years. It is projected to expand from $4.18 billion in 2025 to $4.42 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. In the past, this market’s expansion was primarily driven by growing concerns about hospital-acquired infections, the enlargement of healthcare infrastructure, an increase in surgical and diagnostic procedures, a heightened demand for high-level disinfectants in medical environments, and the adoption of chemical sterilization methods in laboratory settings.

The ortho phthalaldehyde market size is anticipated to undergo significant expansion in the upcoming years, with projections indicating it will reach $5.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.1%. This expected growth within the forecast period is driven by factors such as the tightening of regulatory standards for infection control, an increasing demand for minimally toxic disinfectants, a rise in outpatient surgical procedures, the expansion of biotechnology and diagnostic laboratories, and a greater focus on advanced hospital hygiene systems. Notable trends observed during this period include a growing need for high-level disinfectants in endoscope reprocessing workflows, a wider adoption of rapid-acting sterilants for hospital infection control, the proliferation of automated disinfection systems in diagnostic laboratories, a shift towards low-residue chemical disinfectants to ensure medical device safety, and an increasing preference for stable, high-efficacy aldehyde-based sterilization solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=51790692&type=smp

Ortho Phthalaldehyde Market Industry Drivers: What Is Driving Revenue Growth?

The rising frequency of hospital-acquired infections is anticipated to stimulate the expansion of the ortho phthalaldehyde market in the future. Hospital-acquired infections (HAIs) are illnesses patients acquire during their stay in a healthcare setting, having not been present or in their incubation period upon admission. The increasing occurrence of these infections is attributed to the overuse of invasive medical devices, which create direct pathways for infectious agents to infiltrate the body and initiate disease. Ortho-phthalaldehyde, serving as a high-level disinfectant, contributes to mitigating hospital-acquired infections by efficiently eliminating a broad spectrum of pathogens from medical instruments and surfaces utilized in clinical environments. As an illustration, in May 2024, the Center for Infectious Disease Research and Policy (CIDRAP), a US-based disease research organization, reported that the number of patients experiencing at least one healthcare-acquired infection in hospitals across the European Union and European Economic Area reached nearly 4.3 million annually in 2022 and 2023. Thus, the escalating prevalence of hospital-acquired infections is a key factor driving the ortho phthalaldehyde market’s growth. The rising volume of surgical procedures is projected to stimulate the expansion of the ortho phthalaldehyde market moving forward. Surgical procedures encompass medical interventions utilizing manual or instrumental techniques to treat diseases, injuries, or deformities by cutting, removing, repairing, or replacing body tissues. This increase in surgical procedures stems from the rising prevalence of chronic diseases, which often progress to advanced stages requiring surgical intervention for effective management and improved patient outcomes. Ortho-phthalaldehyde (OPA) supports these procedures by ensuring high-level disinfection of critical medical instruments such as endoscopes and surgical tools, thereby guaranteeing their freedom from harmful microorganisms. For instance, in February 2025, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, around 2,683,000 surgical procedures were carried out using da Vinci surgical systems, up from approximately 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, reflecting steady year-over-year growth in utilization. Therefore, the increasing number of surgical procedures is a significant factor driving the ortho phthalaldehyde market’s growth.

Ortho Phthalaldehyde Market Segments: Where Are The Largest Growth Opportunities?

The ortho phthalaldehyde market covered in this report is segmented –

1) By Product Type: Liquid Ortho-Phthalaldehyde (OPA), Powder Ortho-Phthalaldehyde (OPA)

2) By Purity: Greater Than Or Equal To Ninety-Nine Percent, Less Than Ninety-Nine Percent

3) By Distribution Channel: Direct Sales, Distributors And Wholesalers, Online Medical Supply Platforms, Other Distribution Channel

4) By Application: Endoscope Reprocessing And Disinfection, Medical Device Sterilization, Hospital Surface Disinfection, Laboratory Equipment Sterilization, Dialysis Equipment Cleaning And Disinfection

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Research Institutes, Pharmaceutical And Biotechnology Companies

Subsegments:

1) By Liquid Ortho-Phthalaldehyde (OPA): Ready To Use Solutions, Concentrated Liquid Solutions, Hospital Grade Liquid Solutions, Laboratory Grade Liquid Solutions

2) By Powder Ortho-Phthalaldehyde (OPA): Fine Powder Formulations, Granular Powder Formulations, Industrial Grade Powder, Pharmaceutical Grade Powder

Ortho Phthalaldehyde Market Major Participants And Competitive Dynamics

Major companies operating in the ortho phthalaldehyde market are Thermo Fisher Scientific Inc., Merck KGaA, MP Biomedicals LLC, Simson Pharma Limited, Shodhana Laboratories Pvt. Ltd., Spectrum Chemical Manufacturing Corp., Otto Chemie Pvt. Ltd., Garonit Pharmaceutical, TCI Chemicals (India) Pvt. Ltd., Unilab Chemicals & Pharmaceuticals Pvt. Ltd., Loba Chemie Pvt. Ltd., Muby Chemicals, Freesia Chemicals, Microwin Labs Private Limited, Benzo Chem Industries Pvt. Ltd., N S Chemicals and Consultants Pvt. Ltd., Super Hygienic Chemicals, Affinity Specialty Chemicals, Ebele Cosmeceuticals, RYZE Chemie

Access The Complete Ortho Phthalaldehyde Market Report:

https://www.thebusinessresearchcompany.com/report/ortho-phthalaldehyde-market-report

Ortho Phthalaldehyde Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the ortho phthalaldehyde market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ortho phthalaldehyde market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model